NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in NeuroPace Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q1 2023
- Shares held
- 17.5M
- −166.6K (−0.9%) vs. Q1 2023
- Total value
- $78.6M
- −$3.40M (−4.1%) vs. Q1 2023
- New holders
- 1
- 8 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $406.5M |
| Q3 2025 | 80 | $267.6M |
| Q2 2025 | 99 | $250.8M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.6M |
| Q3 2024 | 48 | $103.2M |
| Q2 2024 | 51 | $113.8M |
| Q1 2024 | 54 | $242.4M |
| Q4 2023 | 41 | $168.4M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $88.9M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| KCK Ltd. | 5,621,111 | $25.2M | 39.57% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,012,281 | $18.0M | 0.35% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,466,214 | $11.1M | 1.23% | +37,500+1.5% | Added |
| Morgan Stanley | 2,358,866 | $10.6M | 0.00% | +100,850+4.5% | Added |
| FMR LLC | 1,223,663 | $5.49M | 0.00% | −269,268−18.0% | Reduced |
| Millennium Management LLC | 628,933 | $2.82M | 0.00% | −102,677−14.0% | Reduced |
| Nantahala Capital Management, LLC | 424,850 | $1.91M | 0.23% | −1,075−0.3% | Reduced |
| Vanguard Group Inc | 378,187 | $1.70M | 0.00% | +81,639+27.5% | Added |
| Kent Lake Capital LLC | 149,205 | $669.9K | 0.31% | +21,529+16.9% | Added |
| Geode Capital Management, LLC | 71,515 | $321.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 60,048 | $269.6K | 0.01% | +8,400+16.3% | Added |
| BlackRock Inc. | 36,117 | $162.2K | 0.00% | +3,646+11.2% | Added |
| State Street Corp | 22,451 | $100.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 17,300 | $78.0K | 0.00% | +2,800+19.3% | Added |
| Northern Trust Corp | 16,106 | $72.3K | 0.00% | −65−0.4% | Reduced |
| Financial Advocates Investment Management | 10,000 | $44.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,500 | $24.7K | 0.00% | −7,516−57.7% | Reduced |
| Royal Bank of Canada | 341 | $2.00K | 0.00% | +341 | New |
| BerganKDV Wealth Management, LLC | 420 | $1.89K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 223 | $1.00K | 0.00% | +4+1.8% | Added |
| Barclays PLC | 118 | $530 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 90 | $404 | 0.00% | −694−88.5% | Reduced |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −25,388−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,052−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,623−100.0% | Sold out |